Back to Search
Start Over
Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
- Source :
-
Gynecologic Oncology . Sep2021, Vol. 162 Issue 3, p575-583. 9p. - Publication Year :
- 2021
-
Abstract
- Urine self-sampling has gained increasing interest for cervical cancer screening. In contrast to analytical performance, little information is available regarding the clinical accuracy for high-risk Human Papillomavirus (hrHPV) testing on urine. VALHUDES is a diagnostic test accuracy study comparing clinical accuracy to detect high-grade cervical precancer (CIN2+) of HPV testing on self-collected compared to clinician-collected samples (NCT03064087). Disease outcome was assessed by colposcopy and histology. The Abbott RealTi me High Risk HPV assay performance was evaluated on Colli-Pee collected first-void urine with cervical outcomes as comparator. As no assay cut-off for urine has been clinically validated, we used the predefined cut-off for cervical samples (CN ≤ 32). Using this cut-off, hrHPV testing was similarly sensitive (relative sensitivity 0.95; 95% CI: 0.88–1.01) and specific (relative specificity 1.03; 95% CI: 0.95–1.13) for detection of CIN2+ compared to testing cervical samples. In the subgroup of women of 30 years and older, similar relative sensitivity (0.97; 95% CI: 0.89–1.05) and specificity (1.02; 95% CI: 0.93–1.12) was found. Additionally, an exploratory cut-off (CN ≤ 33.86) was defined which further improved sensitivity and analytical test performance. HrHPV-DNA based PCR testing on home-collected first-void urine has similar accuracy for detecting CIN2+ compared to cervical samples taken by a clinician. • First study to prove that HPV testing in home-collected first-void urine is a valid alternative to cervical samples. • A HPV DNA-based PCR platform, already used in routine cancer screening, assessed clinical accuracy of urinary HPV testing. • Compared to cervical samples, HPV testing in first-void urine showed equal clinical accuracy for CIN2+. • Outcome is pivotal to widen sampling strategies and reach un(der)-screened women by offering urine self-collection at home. [ABSTRACT FROM AUTHOR]
- Subjects :
- *PAPILLOMAVIRUSES
*URINE
*MEDICAL personnel
*URINALYSIS
*EARLY detection of cancer
Subjects
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 162
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152186952
- Full Text :
- https://doi.org/10.1016/j.ygyno.2021.06.010